Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibiotic resistance of urinary pathogens after kidney transplantation: a 10-year single-center survey in Germany.

Infection·2025
Same author

Rare and risky: a unique case of concurrent chronic pulmonary aspergillosis and lemierre syndrome.

Infection·2024
Same author

Analysis and predictability of technologists' perception of MR exam complexity.

Radiography (London, England : 1995)·2023
Same author

[Summery of the DRG and BDR position paper on coronary computed tomography: clinical evidence and quality of patient care in chronic coronary syndrome].

Radiologie (Heidelberg, Germany)·2023
Same author

[German Radiological Society and the Professional Association of German Radiologists position paper on coronary computed tomography: clinical evidence and quality of patient care in chronic coronary syndrome].

Radiologie (Heidelberg, Germany)·2023
Same author

Accuracy of registration techniques and vascular imaging modalities in fusion imaging for aortic endovascular interventions: a phantom study.

CVIR endovascular·2021

Related Experiment Videos

[Nephrogenic systemic fibrosis--a new interdisciplinary challenge].

O Witzke1, U Hillen, J Barkhausen

  • 1Klinik für Nieren- und Hochdruckkrankheiten, Medizinische Klinik, Universitätsklinikum Essen.

Deutsche Medizinische Wochenschrift (1946)
|December 7, 2007
PubMed
Summary

Nephrogenic systemic fibrosis (NSF) is a severe skin disorder linked to gadolinium contrast agents in patients with kidney failure. Early diagnosis and managing renal function are key, with physiotherapy and photopheresis showing potential benefits.

Related Experiment Videos

Area of Science:

  • Nephrology
  • Dermatology
  • Radiology

Background:

  • Nephrogenic systemic fibrosis (NSF), previously nephrogenic fibrosis dermopathy, is a severe condition exclusively affecting patients with renal failure.
  • Exposure to gadolinium-based contrast agents (GBCAs) used in magnetic resonance imaging (MRI) is strongly associated with NSF development.
  • The disease manifests as skin tightening and swelling, primarily in the limbs, with potential for internal organ involvement and mortality.

Purpose of the Study:

  • To summarize the understanding of Nephrogenic Systemic Fibrosis (NSF).
  • To highlight diagnostic criteria and therapeutic strategies for NSF.
  • To provide guidance on the use of gadolinium-containing contrast agents in patients with renal impairment.

Main Methods:

  • Review of existing literature on NSF.
  • Analysis of diagnostic markers including skin biopsy findings (fibrous tissue, CD34+, factor XIIIa+, CD68+ macrophages).
  • Evaluation of therapeutic interventions and contrast agent precautions.

Main Results:

  • Diagnosis is confirmed by characteristic skin biopsy findings.
  • Restoration of renal function (transplantation or recovery) is the primary treatment goal.
  • Physiotherapy and extracorporeal photopheresis show the best available evidence for therapeutic effect.

Conclusions:

  • Gadodiamide and gadopentetate-dimeglumin are contraindicated in stages 4 and 5 renal failure.
  • Other GBCAs require extreme caution in patients with advanced renal failure.
  • Management of NSF necessitates a multidisciplinary approach focusing on renal function and supportive therapies.